Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11; 14)(q13;q32)

International Journal of Hematology

Volumn 66, Issue 1, 1997, Pages 111-115

  Shimazaki, Chihiro ^a   Goto, Hideo ^a   Araki, Shin ichi ^a   Tatsumi, Tetsuya ^a   Takahashi, Ryoichi ^a   Hirai, Hideyo ^a   Kikuta, Takehisa ^a   Yamagata, Noboru ^a   Ashihara, Eishi ^a   Inaba, Tohru ^a   Fujita, Naohisa ^a   Suzuki, Ritsuro ^b   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Plasma cell leukemia; PRAD1 cyclin D1; t(11; 14)(q13; q32)

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLIN D1; GENE PRODUCT; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CASE REPORT; CELL CYCLE; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION 11; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENE EXPRESSION; HUMAN; MALE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031194592     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00021-2     Document Type: Article

References (24)

1. Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood 1987;69:1617-1621.
2. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell P, Croce C. Clustering of the breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985;315:340-343.
3. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991;6:449-453.
4. Motokura T, Bloom T, Kim HG et al. A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 1991;350:512-515.
5. Seto M, Yamamoto K, Iida S et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992;7:1401-1406.
6. Komatsu H, Iida S, Yamamoto K et al. A variant chromosome translocation at 11q13 identifying PRAD1/Cyclin D1 as the BCL-1 gene. Blood 1994;84:1226-1231.
7. Xiong X, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-699.
8. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993;7:241-245.
9. Bosch F, Jares P, Campe E et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-2732.
10. Dewald GW, Kyle RA, Hicks GA, Greipp PR. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985;66:380-390.
11. Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B. Plasma cell karyotype in multiple myeloma. Blood 1988;71:453-456.
12. Taniwaki M, Nishida K, Takashima T et al. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 1994;84:2283-2290.
13. Jonveaux P, Berger R. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation. Genes Chromosomes Cancer 1992:4:321-325.
14. Paquette RL, Berenson J, Lichtenstein A, McCormic F, Koeffler HP. Oncogenes in multiple myeloma: point mutation of N-ras. Oncogene 1990;5:1659-1663.
15. Ladanyi M, Wang S, Niesvizky R, Feiner H, Michaeli J. Proto-oncogene analysis in multiple myeloma. Am J Pathol 1992;141:949-953.
16. Fiedler W, Weh HJ, Hossfeld DK. Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. Br J Haematol 1992;81:58-61.
17. Meeus P, Stul MS, Mecucci C, Cassiman JJ, Van Den Berghe H. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genet Cytogenet 1995;83:25-27.
18. Raynaud SD, Bekri S, Leroux D et al. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer 1993;8:80-87.
19. Chesi M, Bergsagel L, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996;88:674-681.
20. Yamagata N, Shimazaki C, Goto H et al. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-α. Am J Hematol 1994;45:262-264.
21. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78;1991:259-263.
22. Zhang XG, Gaillard JP, Robillard N et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994;83:3654-3663.
23. Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma-new biological insights and advances in therapy. Blood 1989;73:865-879.
24. Travis P, Sawyer J, Lary C, Hoover R, Barlogie, B. Translocation 11;14 and BCL-1 gene abnormalities in multiple myeloma (MM). Blood 1993;82(Suppl. 1):261a.